Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
RTMS Cuts Smoking by 11 Cigarettes Daily by Boosting Willpower, Study Finds
Researchers at the MUSC Hollings Cancer Center demonstrated that high‑frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex lowered cigarette consumption by an average of 11 cigarettes per day, outperforming reward‑targeting and sham treatments. The findings suggest a brain‑based, motivation‑enhancing approach to smoking cessation.
Argenx Secures FDA Nod to Expand VYVGART to All Adult gMG Patients
argenx announced that the U.S. FDA has approved VYVGART and VYVGART Hytrulo for use in every adult with generalized myasthenia gravis (gMG), regardless of antibody status. The decision follows the Phase 3 ADAPT SERON trial, which demonstrated rapid, sustained symptom improvement across...
Whoop Adds AI‑Driven In‑App Medical Consultations, Expanding Wearable Into Telehealth
Whoop announced a summer 2026 launch of AI‑enhanced, in‑app medical consultations for U.S. members, letting users video‑chat licensed clinicians while sharing real‑time biometric data. The service adds a paid tier on top of the existing subscription, marking the fitness‑tracker’s first...
Choosing Traits: Mercy vs Competitive Advantage in Embryo Selection
Listening to @hsu_steve and @AlexTISYoung discuss the ethics of embryo selection is disorienting. Seems disingenuous to laugh off the difference between screening out Huntington’s and optimizing for height or IQ, as if the distinction is some kind of philosophical naivety. A...
McKesson Posts 18% EPS Rise, Boosts FY2026 Guidance on Strong Pharma Demand
McKesson Corp. announced adjusted earnings of $39.11 per diluted share for fiscal 2026, an 18% jump, and raised its FY2027 guidance to $43.80‑$44.60 per share. The health‑care distributor credited specialty drug demand, AI‑driven cost cuts, and a $5.1 billion shareholder return...
Mabwell Secures FDA IND Clearance for 9MW5211 Antibody, Paving Way for IBD Trials
Mabwell (688062.SH, 02493.HK) announced that the FDA has cleared its investigational new drug application for 9MW5211, a first‑in‑class antibody targeting pathogenic immune cells in inflammatory bowel disease. The clearance enables the company to begin human trials and adds momentum to...
How Corporate Medicine Is Eroding Truth and Patient Dignity
Ronald L. Lindsay, a retired pediatrician, contrasts his early experience in academic medicine—where open debate, error disclosure, and moral safety were routine—with the later reality of corporate‑run health systems that prioritize documentation, metrics, and institutional risk. He recounts a recent...
Traws Pharma Shares Surge 30% on Accelerated Hantavirus Drug Push
Traws Pharma (TRAW) saw its Nasdaq price climb roughly 30% to $2.20 after the company disclosed plans to fast‑track clinical candidates for hantavirus treatment and prevention. The move lifted the stock from an opening of $2.04 to a session high...
Hantavirus and Tuberculosis Cases: Should We Be Worried?
Recent reports highlighted three tuberculosis clusters in Singapore and a suspected hantavirus outbreak on an Atlantic cruise ship. Experts from Duke‑NUS Medical School explain that rodent control is the primary defense against hantavirus, which is carried by local rats but...
Contributor: How Remote Care Is Changing Parkinson Treatment
Remote programming of Abbott’s NeuroSphere Virtual Clinic has accelerated deep brain stimulation (DBS) optimization for Parkinson’s patients, cutting adjustment time from over 15 hours to under an hour. In the ROAM‑DBS trial, participants using the virtual clinic reported symptom improvement...
White House Plans to Fire FDA Chief Marty Makary, Sources Tell WSJ
According to the Wall Street Journal, the Trump administration has signed off on a plan to remove Dr. Marty Makary as FDA commissioner, though officials say the decision is not final. Makary’s tenure has been marked by clashes with the...
CDC Delays Hantavirus Alert, HHS Controls Communication
1. #CDC issued its 1st alert to health providers & public health depts on the cruise ship #hantavirus outbreak overnight. I got it at 12:45 am ET. This should have happened days ago. CDC's communications are tightly controlled by...
Insurance Type May Tie to Transplant Referral Odds in some States
A study of 56,775 dialysis patients in Georgia, North Carolina and South Carolina found that those enrolled in Medicare Advantage (MA) plans have a 7% lower chance of receiving a kidney transplant referral compared with traditional Medicare beneficiaries. The disparity...
Depression Severity May Tie to Vascular Access Type
A recent analysis of 175 hemodialysis patients found that 80% reported minimal depressive symptoms while 10.3% experienced moderate‑to‑severe depression. The study highlighted a stark contrast in depression severity based on vascular access type: patients who began dialysis with a permanent...
Generative Braces Move Into Metal: An Interview with LightForce’s James Lawton
On April 28, 2026 LightForce Orthodontics launched LightBracket Metal, a patient‑specific 3D‑printed metal bracket generated directly from an orthodontist’s digital treatment plan. The product expands the company’s generative braces platform from ceramic to metal, targeting the 65% of patients who...
Patients May Not Understand AKI Risks After Hospital Discharge
A cross‑sectional analysis of 490 patients who experienced stage 2 or higher acute kidney injury (AKI) during hospitalization revealed that objective knowledge of AKI averaged just 37.8%, with perceived understanding scoring 2.5 out of 5. Fewer than one‑third of patients could...
VIDEO: ‘New Era of Oral Therapies’ on Horizon in Psoriasis
At the American Academy of Dermatology meeting, data from phase 3 trials showed that next‑generation TYK2 inhibitors zasocitinib (Takeda) and envudeucitinib (Alumis) achieved significant plaque‑psoriasis reduction by week 24. These oral agents build on the earlier success of deucravacitinib, offering greater specificity...
What Have RFK, Jr. And The Trump Administration Done For Mothers?
Secretary of Health and Human Services Robert F. Kennedy Jr., appointed by the Trump administration, has pursued a series of controversial health policies that target mothers and children. He questioned the safety of acetaminophen in pregnancy, barred pregnant women and children from COVID‑19...
Message by the WHO Director-General to the People of Tenerife Regarding the Hantavirus Response
The World Health Organization’s Director‑General, Tedros, addressed Tenerife residents about the Andes‑strain hantavirus aboard the MV Hondius, which has caused three deaths. WHO assesses the public health risk to the island as low and outlines a controlled disembarkation plan at...
When Doctors Stall, Patients Self‑Prescribe Online
A doctor found out he had an ascending aortic aneurysm because his cardiologist mentioned it in passing. Then, when he asked for a beta blocker through the patient portal, the answer he got back was "he isn't comfortable." He asked...
UCSF Neurologist Finds Psilocybin Can Reset Depressed Brain
UCSF neurologist Robin Carhart‑Harris said a single high‑dose psilocybin treatment produced lasting symptom relief for patients with treatment‑resistant depression, positioning the psychedelic as a structural brain reset rather than a daily chemical tweak.
Bridging the Health Equity Gap with Artificial Intelligence
Artificial intelligence is poised to transform health care, offering earlier disease detection and decision‑support tools that could extend specialist expertise to underserved clinics. However, the technology inherits the biases of U.S. health‑care data, which often under‑represents uninsured, undocumented and digitally...
Michigan's Rx Kids Cash Prescription Cuts Infant Maltreatment Investigations by 32%
A peer‑reviewed JAMA Pediatrics study shows Michigan State University's Rx Kids cash‑prescription program reduced infant maltreatment investigations in Flint by 7 percentage points—a 32% relative drop—preventing roughly 57 investigations in its first year. The findings bolster calls for broader economic‑support...
Family of Jenna Dorman Calls for Stronger Postpartum Depression Supports in B.C.
The family of tech executive Jenna Dorman, who died by suicide in November 2024, is demanding expanded postpartum mental‑health services in British Columbia. Their appeal coincides with a $32,000 fundraising drive and a private‑member bill backed by all provincial MLAs.
Weekly Neuroscience Update
A wave of recent neuroscience studies uncovers new mechanisms and risk factors across a spectrum of disorders. MRI data link lower abdominal fat to slower brain atrophy and better cognition, while a single psilocybin dose appears to trigger lasting anatomical...
Knox Lane to Take Cross Country Healthcare Private in $437 Million Deal
Knox Lane, a $3.5 billion‑asset private equity firm, announced a definitive agreement to acquire publicly traded Cross Country Healthcare for $437 million. The deal follows a collapsed $615 million acquisition attempt by Aya Healthcare and underscores continued PE appetite for staffing services amid...
FDA Approves Veppanu, First PROTAC Therapy for ESR1‑Mutant Breast Cancer
The U.S. Food and Drug Administration has approved Veppanu (vepdegestrant), the first PROTAC drug for estrogen‑receptor‑mutant breast cancer. The decision follows the VERITAC‑2 trial, where Veppanu extended median progression‑free survival to five months in the ESR1‑mutant subgroup, compared with 2.1...
Samsung Galaxy Watch 6 Predicts Fainting Episodes with 84% Accuracy in Clinical Study
Samsung announced that its Galaxy Watch 6 can predict vasovagal syncope up to five minutes before onset, achieving 84.6% accuracy, 90% sensitivity and 64% specificity in a study of 132 patients. The result could reshape wearable health monitoring, but experts...
American Healthcare REIT Q1 2026: COO Gabriel Willhite Drives 12% NOI Growth Amid Market Volatility
American Healthcare REIT reported a 12.1% same‑store NOI increase in Q1 2026, highlighted by $162.8 million of SHOP acquisitions and a 31.6% rise in normalized FFO per share. COO Gabriel Willhite credited operational discipline and strategic capital moves for the performance...
North Carolina Medicaid Autism Therapy Billings Surge 47,000%, Sparking Fraud Probe
North Carolina State Auditor Dave Boliek has uncovered a 47,000% increase in Medicaid autism therapy billing, from $1.4 million to over $660 million, prompting a statewide audit and calls for stricter oversight. Similar billing explosions in Ohio and other red states are...
Kaohsiung to Fine Cosmetic Surgery Chain Branches over Regulatory Violations
Taiwan's Kaohsiung Department of Health fined two Airlee Group cosmetic‑surgery branches after inspections uncovered regulatory breaches. The Zuoying location failed to list medical‑institution names on controlled‑drug prescriptions and faces fines of NT$60,000‑NT$300,000 (US$1,915‑US$9,575). The Sinsing branch stored expired controlled drugs,...
Nanoparticle Platform Achieves 100% Survival in Drug‑Resistant Cancer Mice
Researchers led by Prof. Eijiro Miyako at Tohoku University unveiled a multifunctional nanoparticle that first blocks P‑glycoprotein pumps, then releases doxorubicin, and adds near‑infrared photothermal heating. In mouse models of multidrug‑resistant tumors the treatment caused full tumor regression and 100%...
Isomorphic Labs Nears $2 Billion Funding Round Led by Thrive Capital
Isomorphic Labs, the DeepMind‑spun AI drug‑discovery startup, is negotiating a financing round of more than $2 billion. Thrive Capital will lead the round, with Alphabet also participating, positioning the company for global expansion and a next‑generation drug‑design platform.
What’s Your Heart’s GPA?
The American Heart Association’s Life’s Essential 8 (LE8) provides a 0‑to‑100 composite score that aggregates four health‑behavior and four health‑factor metrics into a single cardiovascular health grade. The average U.S. adult scores 65, roughly a D+ on traditional grading scales,...
China's NMPA Grants Breakthrough Therapy Designation to NHWD-870 for Rare NUT Carcinoma
Zhejiang Wenda Pharmaceutical's oral BET inhibitor NHWD-870 has earned breakthrough therapy designation from China's NMPA for advanced thoracic NUT carcinoma, after Phase II data showed a 45% response rate and median survival of 9.33 months. The designation accelerates review and...
Big Apple Exclusive: Dr. McCullough Goes Live to Unveil Potential Cancer Breakthrough
In this episode, Dr. Peter McCullough, chief scientific officer of a wellness company, discusses an observational report on the off‑label use of two generic drugs—ivermectin and mebendazole—in cancer patients. The study, now under peer review, found that nearly half of participants...
The $227 Million Bet on North-Central Wisconsin’s Healthcare Future
Aspirus Health is investing $227 million in a privately funded expansion of its Wausau Hospital, slated for completion in 2028. The project adds 48 intermediate‑care beds, a 16‑bed observation unit and a new fixed PET/CT scanner, increasing total patient capacity by...
Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
Public health journalist Céline Gounder highlighted a hantavirus outbreak aboard a transatlantic cruise ship across PBS NewsHour, Fox LiveNow, CBS Mornings, and NPR’s Morning Edition in early May. Simultaneously, KFF senior editor Elisabeth Rosenthal warned that emergency‑room boarding delays are...
Re: Make Compassion Visible in Emergency Medicine Again
In a letter to the BMJ, GP Ruth L. Evans reflects on the call for renewed compassion in emergency medicine, arguing that clinicians must first care for themselves and their colleagues. She describes how mounting patient demand and dwindling resources...
Modicus Prime Announces $8M in Funding to Enable AI Audit Readiness Across Pharma
Modicus Prime announced it has closed an additional $4.5 million financing round led by Frist Cressey Ventures, bringing its total capital to $8 million. The funds will be used to scale its Trustworthy AI Compliance Software, which embeds a compliance layer into...
AI Predicts Chemoresistance in Bladder Cancer
Researchers published a machine‑learning framework that fuses tumor transcriptome profiles with high‑resolution digital pathology to forecast chemoresistance in muscle‑invasive bladder cancer (MIBC). The multimodal model outperformed single‑data approaches, accurately distinguishing resistant from responsive tumors in extensive validation cohorts. By pinpointing...
SuperDNA: AI-Driven Biotech Hub Accelerates Drug Discovery
Welcome to SuperDNA Up City - this will be the true automation biotechnology + AI Disneyland with 10 thousand humans in the loop. Most people do not realize that even today, with 30 developmental candidates some of which often trigger...
Boosting Physician AI Adoption Through Prescriptive Strategies
Prescribing Change: Improving #AI Adoption Among Physicians by Michel van Harten @Forbes Learn more: https://t.co/4U52ChjK9J #ArtificialIntelligence #MachineLearning #ML https://t.co/dMKeiDHEJQ
17-Alpha Estradiol - Another Top Anti-Aging Drug
The post details efforts to source 17α‑estradiol (alfatradiol) for anti‑aging and renal‑protective research, listing vendors and pricing—including Octagonchem’s $1,200 for 100 g and Shanghai Jizhi’s roughly $80 for 200 mg (≈¥568). It proposes a group‑buy workflow that starts with small‑scale sampling, purity...
Isomorphic Labs Eyes $2B Raise, Biotech’s Second‑largest
Great scoop from @RebeccaTorrenc5 & @mhbergen on Isomorphic Labs in "advanced discussions to raise more than $2 billion in a new round of funding" led by Thrive Capital Would be second-largest VC raise ever in biotech, only behind $3B for...
Politics Controls Medicare Drug Coverage, Shapes Private Insurers
Politics does determine which drugs Medicare &Medicaid pay for, and through those decisions, most private insurers. Wake up dude.
Billions Spent on Research We Could Simply Stop
We spend $50 billion now on biomedical research through NIH, and several billion more through other agencies. We could "save" that money by not spending it, yet we do. Same story.
Low‑Cost Vaccines and Open Science Aren’t Evil
Hmmm, presumably making low-cost vaccines to help humanity, $2-4 per dose, no onerous patent restrictions, pioneering a way to bypass big pharma, helping the nation through a terrible pandemic, writing books with academic presses on history of science/medicine, constitute evil?
Government Sets Drug Funding, Market Determines Prices
Guess what, the government NOW decides how much it will pay and for which drugs. It will have to decide which lines of research it will support, as is the case now. The price wll be left to the market,...
Hospitals Serve All; President Delivers Nationwide Improvements
Many times I posted about the ongoing renovations at Mpilo Hospital… Your problem is thinking that hospitals are tribal or regional establishments, they are for everyone. President @edmnangagwa is DELIVERING, even NEGAHOLICS like you will appreciate one day… https://t.co/YR3ZVuiPbT